{"id":30052,"date":"2021-04-01T12:00:00","date_gmt":"2021-04-01T12:00:00","guid":{"rendered":"https:\/\/www.euforea.org\/news\/exploration-des-nouveaux-traitements-biologiques-dans-la-prise-en-charge-de-lasthme\/"},"modified":"2021-04-01T12:00:00","modified_gmt":"2021-04-01T12:00:00","slug":"exploration-des-nouveaux-traitements-biologiques-dans-la-prise-en-charge-de-lasthme","status":"publish","type":"news","link":"https:\/\/www.euforea.org\/fr\/news\/exploration-des-nouveaux-traitements-biologiques-dans-la-prise-en-charge-de-lasthme\/","title":{"rendered":"Exploration des nouveaux traitements biologiques dans la prise en charge de l\u2019asthme"},"content":{"rendered":"<div class=\"paragraph paragraph--text-columns paragraph-id--1230 paragraph--type--text-columns paragraph--view-mode--default clearfix paragraph--text-columns--1col\">\n<div class=\"inner--wide\">\n<div class=\"text__text text text--paragraph\">\n<p>De nombreuses personnes sont trait\u00e9es pour un asthme s\u00e9v\u00e8re non contr\u00f4l\u00e9, associ\u00e9 \u00e0 un risque \u00e9lev\u00e9 d\u2019hospitalisation. \u00c0 certains patients souffrant de diff\u00e9rents types d\u2019asthme, un nouveau type de traitement a \u00e9t\u00e9 propos\u00e9 en compl\u00e9ment de leurs m\u00e9dicaments habituels : les anticorps monoclonaux, \u00e9galement appel\u00e9s bioth\u00e9rapies. <\/p>\n<p>Le professeur Michael Wechsler du National Jewish Health Hospital de Denver, aux \u00c9tats-Unis, dont les recherches portent sur les nouvelles th\u00e9rapies et les traitements biologiques pour l\u2019asthme et les maladies apparent\u00e9es, aborde les d\u00e9fis actuels de la prise en charge de l\u2019asthme par les bioth\u00e9rapies. Vous d\u00e9couvrirez comment les bioth\u00e9rapies peuvent am\u00e9liorer les sympt\u00f4mes et r\u00e9duire les crises d\u2019asthme, apprendrez les diff\u00e9rences entre les traitements biologiques et les traitements classiques, et identifierez les groupes de patients susceptibles d\u2019\u00eatre trait\u00e9s avec succ\u00e8s par ces th\u00e9rapies. <\/p>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"paragraph paragraph--text-columns paragraph-id--1231 paragraph--type--text-columns paragraph--view-mode--default clearfix paragraph--text-columns--1col\">\n<div class=\"inner--wide\">\n<div class=\"text__text text text--paragraph\">\n<div class=\"video-container\"><center><iframe title=\"Lecteur vid\u00e9o YouTube\" src=\"https:\/\/www.youtube.com\/embed\/SSqD9hM40SM?rel=0\" width=\"560\" height=\"315\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/center><\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>De nombreuses personnes sont trait\u00e9es pour un asthme s\u00e9v\u00e8re non contr\u00f4l\u00e9, associ\u00e9 \u00e0 un risque \u00e9lev\u00e9 d\u2019hospitalisation. \u00c0 certains patients souffrant de diff\u00e9rents types d\u2019asthme, un nouveau type de traitement a \u00e9t\u00e9 propos\u00e9 en compl\u00e9ment de leurs m\u00e9dicaments habituels : les anticorps monoclonaux, \u00e9galement appel\u00e9s bioth\u00e9rapies. Le professeur Michael Wechsler du National Jewish Health Hospital de Denver, aux \u00c9tats-Unis, dont les recherches portent sur les nouvelles th\u00e9rapies et les traitements biologiques pour l\u2019asthme et les maladies apparent\u00e9es, aborde les d\u00e9fis actuels de la prise en charge de l\u2019asthme par les bioth\u00e9rapies. Vous d\u00e9couvrirez comment les bioth\u00e9rapies peuvent am\u00e9liorer les sympt\u00f4mes et r\u00e9duire les crises d\u2019asthme, apprendrez les diff\u00e9rences entre les traitements biologiques et les traitements classiques, et identifierez les groupes de patients susceptibles d\u2019\u00eatre trait\u00e9s avec succ\u00e8s par ces th\u00e9rapies.<\/p>\n","protected":false},"author":1,"featured_media":30073,"comment_status":"open","ping_status":"closed","template":"","meta":{"footnotes":""},"categories":[169],"tags":[172,175,280,170,171],"class_list":["post-30052","news","type-news","status-publish","has-post-thumbnail","hentry","category-emissions-dactualite-euforea","tag-asthme","tag-biotherapies","tag-traitements","tag-professionnels-de-sante","tag-actualites-euforea"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.5 (Yoast SEO v28.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Exploration des nouveaux traitements biologiques dans la prise en charge de l\u2019asthme - EUFOREA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.euforea.org\/news\/exploration-des-nouveaux-traitements-biologiques-dans-la-prise-en-charge-de-lasthme\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Exploration des nouveaux traitements biologiques dans la prise en charge de l\u2019asthme\" \/>\n<meta property=\"og:description\" content=\"De nombreuses personnes sont trait\u00e9es pour un asthme s\u00e9v\u00e8re non contr\u00f4l\u00e9, associ\u00e9 \u00e0 un risque \u00e9lev\u00e9 d\u2019hospitalisation. \u00c0 certains patients souffrant de diff\u00e9rents types d\u2019asthme, un nouveau type de traitement a \u00e9t\u00e9 propos\u00e9 en compl\u00e9ment de leurs m\u00e9dicaments habituels : les anticorps monoclonaux, \u00e9galement appel\u00e9s bioth\u00e9rapies. Le professeur Michael Wechsler du National Jewish Health Hospital de Denver, aux \u00c9tats-Unis, dont les recherches portent sur les nouvelles th\u00e9rapies et les traitements biologiques pour l\u2019asthme et les maladies apparent\u00e9es, aborde les d\u00e9fis actuels de la prise en charge de l\u2019asthme par les bioth\u00e9rapies. Vous d\u00e9couvrirez comment les bioth\u00e9rapies peuvent am\u00e9liorer les sympt\u00f4mes et r\u00e9duire les crises d\u2019asthme, apprendrez les diff\u00e9rences entre les traitements biologiques et les traitements classiques, et identifierez les groupes de patients susceptibles d\u2019\u00eatre trait\u00e9s avec succ\u00e8s par ces th\u00e9rapies.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.euforea.org\/news\/exploration-des-nouveaux-traitements-biologiques-dans-la-prise-en-charge-de-lasthme\/\" \/>\n<meta property=\"og:site_name\" content=\"EUFOREA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/euforea\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@euforea\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/exploration-des-nouveaux-traitements-biologiques-dans-la-prise-en-charge-de-lasthme\\\/\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/exploration-des-nouveaux-traitements-biologiques-dans-la-prise-en-charge-de-lasthme\\\/\",\"name\":\"Exploration des nouveaux traitements biologiques dans la prise en charge de l\u2019asthme - EUFOREA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/exploration-des-nouveaux-traitements-biologiques-dans-la-prise-en-charge-de-lasthme\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/exploration-des-nouveaux-traitements-biologiques-dans-la-prise-en-charge-de-lasthme\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Exploring20Novel20Biologics20Treatment20in20Asthma20Care.png\",\"datePublished\":\"2021-04-01T12:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/exploration-des-nouveaux-traitements-biologiques-dans-la-prise-en-charge-de-lasthme\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.euforea.org\\\/news\\\/exploration-des-nouveaux-traitements-biologiques-dans-la-prise-en-charge-de-lasthme\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/exploration-des-nouveaux-traitements-biologiques-dans-la-prise-en-charge-de-lasthme\\\/#primaryimage\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Exploring20Novel20Biologics20Treatment20in20Asthma20Care.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Exploring20Novel20Biologics20Treatment20in20Asthma20Care.png\",\"width\":1280,\"height\":720},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/exploration-des-nouveaux-traitements-biologiques-dans-la-prise-en-charge-de-lasthme\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/choisissez-votre-parcours\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Exploration des nouveaux traitements biologiques dans la prise en charge de l\u2019asthme\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#website\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/\",\"name\":\"EUFOREA\",\"description\":\"Inspiring the Future of Respiratory Care\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.euforea.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#organization\",\"name\":\"EUFOREA\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"width\":500,\"height\":500,\"caption\":\"EUFOREA\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/euforea\\\/\",\"https:\\\/\\\/x.com\\\/euforea\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/euforea\",\"https:\\\/\\\/www.youtube.com\\\/c\\\/EUFOREA\",\"https:\\\/\\\/www.instagram.com\\\/euforeaofficial\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Exploration des nouveaux traitements biologiques dans la prise en charge de l\u2019asthme - EUFOREA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.euforea.org\/news\/exploration-des-nouveaux-traitements-biologiques-dans-la-prise-en-charge-de-lasthme\/","og_locale":"fr_FR","og_type":"article","og_title":"Exploration des nouveaux traitements biologiques dans la prise en charge de l\u2019asthme","og_description":"De nombreuses personnes sont trait\u00e9es pour un asthme s\u00e9v\u00e8re non contr\u00f4l\u00e9, associ\u00e9 \u00e0 un risque \u00e9lev\u00e9 d\u2019hospitalisation. \u00c0 certains patients souffrant de diff\u00e9rents types d\u2019asthme, un nouveau type de traitement a \u00e9t\u00e9 propos\u00e9 en compl\u00e9ment de leurs m\u00e9dicaments habituels : les anticorps monoclonaux, \u00e9galement appel\u00e9s bioth\u00e9rapies. Le professeur Michael Wechsler du National Jewish Health Hospital de Denver, aux \u00c9tats-Unis, dont les recherches portent sur les nouvelles th\u00e9rapies et les traitements biologiques pour l\u2019asthme et les maladies apparent\u00e9es, aborde les d\u00e9fis actuels de la prise en charge de l\u2019asthme par les bioth\u00e9rapies. Vous d\u00e9couvrirez comment les bioth\u00e9rapies peuvent am\u00e9liorer les sympt\u00f4mes et r\u00e9duire les crises d\u2019asthme, apprendrez les diff\u00e9rences entre les traitements biologiques et les traitements classiques, et identifierez les groupes de patients susceptibles d\u2019\u00eatre trait\u00e9s avec succ\u00e8s par ces th\u00e9rapies.","og_url":"https:\/\/www.euforea.org\/news\/exploration-des-nouveaux-traitements-biologiques-dans-la-prise-en-charge-de-lasthme\/","og_site_name":"EUFOREA","article_publisher":"https:\/\/www.facebook.com\/euforea\/","twitter_card":"summary_large_image","twitter_site":"@euforea","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.euforea.org\/news\/exploration-des-nouveaux-traitements-biologiques-dans-la-prise-en-charge-de-lasthme\/","url":"https:\/\/www.euforea.org\/news\/exploration-des-nouveaux-traitements-biologiques-dans-la-prise-en-charge-de-lasthme\/","name":"Exploration des nouveaux traitements biologiques dans la prise en charge de l\u2019asthme - EUFOREA","isPartOf":{"@id":"https:\/\/www.euforea.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.euforea.org\/news\/exploration-des-nouveaux-traitements-biologiques-dans-la-prise-en-charge-de-lasthme\/#primaryimage"},"image":{"@id":"https:\/\/www.euforea.org\/news\/exploration-des-nouveaux-traitements-biologiques-dans-la-prise-en-charge-de-lasthme\/#primaryimage"},"thumbnailUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Exploring20Novel20Biologics20Treatment20in20Asthma20Care.png","datePublished":"2021-04-01T12:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.euforea.org\/news\/exploration-des-nouveaux-traitements-biologiques-dans-la-prise-en-charge-de-lasthme\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.euforea.org\/news\/exploration-des-nouveaux-traitements-biologiques-dans-la-prise-en-charge-de-lasthme\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.euforea.org\/news\/exploration-des-nouveaux-traitements-biologiques-dans-la-prise-en-charge-de-lasthme\/#primaryimage","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Exploring20Novel20Biologics20Treatment20in20Asthma20Care.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Exploring20Novel20Biologics20Treatment20in20Asthma20Care.png","width":1280,"height":720},{"@type":"BreadcrumbList","@id":"https:\/\/www.euforea.org\/news\/exploration-des-nouveaux-traitements-biologiques-dans-la-prise-en-charge-de-lasthme\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.euforea.org\/fr\/choisissez-votre-parcours\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/www.euforea.org\/news\/"},{"@type":"ListItem","position":3,"name":"Exploration des nouveaux traitements biologiques dans la prise en charge de l\u2019asthme"}]},{"@type":"WebSite","@id":"https:\/\/www.euforea.org\/#website","url":"https:\/\/www.euforea.org\/","name":"EUFOREA","description":"Inspiring the Future of Respiratory Care","publisher":{"@id":"https:\/\/www.euforea.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.euforea.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.euforea.org\/#organization","name":"EUFOREA","url":"https:\/\/www.euforea.org\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.euforea.org\/#\/schema\/logo\/image\/","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","width":500,"height":500,"caption":"EUFOREA"},"image":{"@id":"https:\/\/www.euforea.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/euforea\/","https:\/\/x.com\/euforea","https:\/\/www.linkedin.com\/company\/euforea","https:\/\/www.youtube.com\/c\/EUFOREA","https:\/\/www.instagram.com\/euforeaofficial\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/news\/30052","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/types\/news"}],"author":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/comments?post=30052"}],"version-history":[{"count":0,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/news\/30052\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/media\/30073"}],"wp:attachment":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/media?parent=30052"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/categories?post=30052"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/tags?post=30052"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}